Argentina vs Liberia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Argentina
79.0%
in 2025
Liberia
80.0%
in 2025
Argentina rank
119th
Liberia rank
116th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Argentina
- Liberia
How they compare
Liberia currently reports 80.0% against 79.0% in Argentina, a difference of 1.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Liberia ahead.
Argentina ranks 119th and Liberia ranks 116th of 192 countries.
Argentina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 62.6% | 35.8% | 26.8% | Argentina |
| 2020s | 77.0% | 74.0% | 3.0% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Argentina or Liberia?
- Liberia, at 80.0% against 79.0% in Argentina as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Argentina and Liberia?
- 1.0%, with Liberia ahead.
- How many years of comparable data are there for Argentina and Liberia?
- 18 years are reported by both, from 2008 to 2025.
- How do Argentina and Liberia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Argentina ranks 119th and Liberia ranks 116th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.